Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-3 of 3 for your search:
Drug:
tobramycin sulfate
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Placebo-Controlled Study of the Inhibition of Radiotherapy-Induced Stomatitis with Chlorhexidine Mouthwash or Oral Antibiotics (Tobramycin/Polymixin E/Amphotericin B) in Patients Receiving Radiotherapy to the Oral Cavity
Phase:
Phase III
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCCTG-909253
, MAYO-909253, NCI-P91-0013
2.
Phase II Combination Chemotherapy with 5-FU and Oral Antibiotics, Vancomycin and Tobramycin, for Metastatic Colorectal Carcinoma
Phase:
Phase II
Type:
Supportive care, Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
DFCI-75112
3.
Chemotherapy with CHOP-BLEO plus Maintenance with OAP in PEPA Program for Diffuse Histiocytic Lymphoma
Phase:
No phase specified
Type:
Supportive care, Treatment
Status:
Closed
Age:
15 to 65
Sponsor:
Protocol IDs:
MDA-DT-7806
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute